Polymer based solutions of bupranolol hydrochloride for intranasal systemic delivery

Journal of Drug Targeting

Volumn 19, Issue 3, 2011, Pages 204-211

  Mishra, Brahmeshwar ^a   Sankar, C ^a   Mishra, Madhusmita ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

bioavailability; Bupranolol hydrochloride; intranasal delivery; polymeric solutions

Indexed keywords

ALGINIC ACID; BUPRANOLOL; CARBOMER; CARBOXYMETHYLCELLULOSE; CHITOSAN; HYDROXYPROPYLCELLULOSE; ISOPRENALINE; METHYLCELLULOSE; POLYMER; POLYVINYL ALCOHOL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BINDING; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; GELATION; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; NOSE IRRITATION; NOSE NECROSIS; PH; POLYMERIZATION; PRIORITY JOURNAL; RABBIT; RAT; TACHYCARDIA; TEMPERATURE; VISCOSITY;

ADHESIVENESS; ADMINISTRATION, INTRANASAL; ADMINISTRATION, MUCOSAL; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BUPRANOLOL; DRUG STABILITY; FEMALE; HYDROGEN-ION CONCENTRATION; MALE; POLYMERS; RABBITS; SOLUTIONS;

EID: 79952651642     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2010.492520     Document Type: Article

References (33)

1. Ahuja A, Khar RK, Ali J. (1997). Mucoadhesive drug delivery system. Drug Dev Ind Pharm, 23, 489-515.
2. Aikawa K, Mitsutake N, Uda H, Tanaka S, Shimamura H, Aramaki Y, Tsuchiya S. (1998). Drug release from pH-response polyvinylacetal diethylaminoacetate hydrogel and application to nasal delivery. Int J Pharm 168, 181-188. (Pubitemid 28349959)
3. Aspden TJ, Illum L, Skaugrud O. (1996). Chitosan as a nasal delivery system: Evaluation of insulin absorption enhancement and efect on nasal membrane integrity using rat models. Eur J Pharm Sci, 4, 23-31. (Pubitemid 26016570)
4. Aspden TJ, Mason JD, Jones NS, Lowe J, Skaugrud O, Illum L. (1997). Chitosan as a nasal delivery system: the efect of chitosan solutions on in vitro and in vivo mucociliary transport rates in human turbinates and volunteers. J Pharm Sci, 86, 509-513. (Pubitemid 27154770)
5. Behl CR, Pimplaskar HK, Sileno AP, deMeireles J, Romeo VD. (1998). Efects of physicochemical properties and other factors on systemic nasal drug delivery. Adv Drug Deliv Rev, 29, 89-116. (Pubitemid 28044088)
6. Chelladurai S, Mishra M, Mishra B. (2008). Design and evaluation of bioadhesive in-situ nasal gel of ketorolac tromethamine. Chem Pharm Bull, 56, 1596-1599.
7. Chu JS, Chandrasekharan R, Amidon GL, Weiner ND, Goldberg AH. (1991). Viscometric study of polyacrylic acid systems as mucoadhesive sustained-release gels. Pharm Res, 8, 1408-1412.
8. Cordes G, Fischer W, Legler U, Wolf HM. (1988). Development of a novel transedermal therapeutic system for bupranolol. Ter Res, 8, 139-153.
9. Harris AS, Ohlin M, Lethagen S, Nilsson IM. (1988). Efects of concentration and volume on nasal bioavailability and biological response to desmopressin. J Pharm Sci, 77, 337-339.
10. Higuchi WI. (1962).Te analysis of data on the medicament release from ointments. J Pharm Sci, 51, 802-804.
11. Johnson P, Rainsford KD. (1972). Te physical properties of mucus: preliminary observations on the sedimentation behaviour of porcine gastric mucus. Biochim Biophys Acta, 286, 72-78.
12. Junginger HE. (1991). Mucoadhesive hydrogels. Pharm Ind, 53, 1056-1065.
13. Kissel T, Drewe J, Bantle S, Rummelt A, Beglinger C. (1992). Tolerability and absorption enhancement of intranasally administered octreotide by sodium taurodihydrofusidate in healthy subjects. Pharm Res, 9, 52-57.
14. Lorenzo-Lamosa ML, Remuñán-López C, Vila-Jato JL, Alonso MJ. (1998). Design of microencapsulated chitosan microspheres for colonic drug delivery. J Control Release, 52, 109-118. (Pubitemid 28123178)
15. Madsen F, Eberth K, Smart JD. (1998). A rheological examination of the mucoadhesive/mucus interaction: the efect of mucoadhesive type and concentration. J Control Release, 50, 167-178. (Pubitemid 28044111)
16. Mishra B, Panayam J, Sharma AV. (1999). Mechanisms of drug release control by osmotic additives from multiple w/o/w emulsions containing diclofenac sodium. Acta Pharm Turc, 41, 58-61. (Pubitemid 29358517)
17. Morimoto K, Tabata H, Morisaka K. (1987). Nasal absorption of nifedipine from gel preparations in rats. Chem Pharm Bull, 35, 3041-3044. (Pubitemid 17135860)
18. Morimoto K, Morisaka K, Kamada A. (1985). Enhancement of nasal absorption of insulin and calcitonin using polyacrylic acid gel. J Pharm Pharmacol, 37, 134-136. (Pubitemid 15162016)
19. Nakamura F, Ohta R, Machida Y, Nagai T. (1996).In vitro and in vivo nasal mucoadhesion of some water soluble polymers. Int J Pharm, 134, 173-181. (Pubitemid 26174999)
20. Park H, Amiji M, Park K. (1989). Mucoadhesive hydrogel efective at neutral pH. Proc Int Sym Control Rel Bioact Mater, 16, 217-218.
21. Pennington AK, Ratclife JH, Wilson CG, Hardy JG. (1988). Te Infuence of solution viscosity on nasal spray deposition and clearance. Int J Pharm, 43, 221-224.
22. Peppas NA. (1985). Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv, 60, 110-111.
23. Rajinikanth PS, Sankar C, Mishra B. (2003). Sodium alginate microspheres of metoprolol tartrate for intranasal systemic delivery: development and evaluation. Drug Deliv, 10, 21-28. (Pubitemid 36205993)
24. Remigius UA, Jorissen M, Willems T, Kinget R, Verbeke N. (2003). Mechanistic appraisal of the efects of some protease inhibitors on ciliary beat frequency in a sequential cell culture system of human nasal epithelium. Eur J Pharm Biopharm, 55, 283-289. (Pubitemid 36561555)
25. Reynolds, JEF. (Ed.), Bupranolol Hydrochloride. Martindale, Te Extra Pharmcopoeia, Te Pharmaceutical Press, London, 1993, pp.631.
26. Sankar C, Mishra B. (2003). Development and in vitro evaluations of gelatin A microspheres of ketorolac tromethamine for intranasal administration. Acta Pharm, 53, 101-110. (Pubitemid 36850881)
27. Sankar C, Rani M, Srivastava AK, Mishra B. (2001a). Chitosan based pentazocine microspheres for intranasal systemic delivery: development and biopharmaceutical evaluation. Pharmazie, 56, 223-226. (Pubitemid 32209948)
28. Sankar C, Srivastava AK, Mishra B. (2001b). Cross-linked chitosan microspheres of pentazocine for intranasal administration, Acta Pharm Turc, 42, 11-15. (Pubitemid 32335679)
29. Shin SC, Cho CW, Choi HK, Oh IJ. (2000). Enhanced efcacy by percutaneous absorption of piroxicam from the poloxamer gel in rats. Int J Pharm, 193, 213-218.
30. Smith J, Wood E, Dornish M. (2004). Efect of chitosan on epithelial cell tight junctions. Pharm Res, 21, 43-49. (Pubitemid 38122290)
31. Tur K.M, Ch'ng HS. (1998). Evaluation of possible mechanism of bioadhesion. Int J Pharm. 160, 61-74.
32. Washington N, Steele RJ, Jackson SJ, Bush D, Mason J, Gill DA, Pitt K, Rawlins DA. (2000). Determination of baseline human nasal pH and the efect of intranasally administered bufers. Int J Pharm, 198, 139-146. (Pubitemid 30184851)
33. Wellstein A, Küppers H, Pitschner HF, Palm D. (1986). Transdermal delivery of bupranolol: pharmacodynamics and beta-adrenoceptor occupancy. Eur J Clin Pharmacol, 31, 419-422. (Pubitemid 17018779)